1. Who, . Unaids, and . Unicef, Towards Universal Access Scaling up priority HIV/AIDS interventions in the health sector Progress Report Available on http://www.who.int/hiv/pub Antiretroviral therapy for HIV infection in adults and adolescents in resourcelimited settings: Towards universal access. Recommendations for a public health approach Available on http, 2002.

J. Jackson, P. Musoke, T. Fleming, L. Guay, D. Bagenda et al., Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial, The Lancet, vol.362, issue.9387, pp.859-868, 2003.
DOI : 10.1016/S0140-6736(03)14341-3

D. Moodley, J. Moodley, H. Coovadia, G. Gray, J. Mcintyre et al., A Multicenter Randomized Controlled Trial of Nevirapine Versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother???to???Child Transmission of Human Immunodeficiency Virus Type 1, The Journal of Infectious Diseases, vol.187, issue.5, pp.725-735, 2003.
DOI : 10.1086/367898

M. Baylor and R. Johann-liang, Hepatotoxicity Associated With Nevirapine Use, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.35, issue.5, pp.538-547, 2004.
DOI : 10.1097/00126334-200404150-00014

J. Leith, P. Piliero, S. Storfer, D. Mayers, and R. Hinzmann, Appropriate Use of Nevirapinefor Long???Term Therapy, The Journal of Infectious Diseases, vol.192, issue.3, pp.545-551, 2005.
DOI : 10.1086/431606

J. Stern, P. Robinson, J. Love, S. Lanes, M. Imperiale et al., A Comprehensive Hepatic Safety Analysis of Nevirapine in Different Populations of HIV Infected Patients*, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.34, issue.1, pp.21-33, 2003.
DOI : 10.1097/00126334-200309011-00005

J. Hitti, L. Frenkel, A. Stek, S. Nachman, D. Baker et al., Maternal Toxicity With Continuous Nevirapine in Pregnancy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.36, issue.3, pp.772-778, 2004.
DOI : 10.1097/00126334-200407010-00002

F. Lyons, S. Hopkins, B. Kelleher, A. Mcgeary, G. Sheehan et al., Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy, HIV Medicine, vol.34, issue.4, pp.255-60, 2006.
DOI : 10.1097/00002030-200201250-00020

E. João, G. Calvet, J. Menezes, D. Ippolito, M. Cruz et al., Nevirapine toxicity in a cohort of HIV-1???infected pregnant women, American Journal of Obstetrics and Gynecology, vol.194, issue.1, pp.199-202, 2006.
DOI : 10.1016/j.ajog.2005.05.015

M. Marazzi, P. Germano, G. Liotta, G. Guidotti, S. Loureiro et al., Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women, HIV Medicine, vol.92, issue.5, pp.338-382, 2006.
DOI : 10.1086/428093

N. Phanuphak, T. Apornpong, S. Teeratakulpisarn, S. Chaithongwongwatthana, C. Taweepolcharoen et al., Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women, HIV Medicine, vol.40, issue.2, pp.357-66, 2007.
DOI : 10.1097/01.aids.0000168973.59466.14

L. Myer, M. Rabkin, E. Abrams, A. Rosenfield, and W. El-sadr, Focus on Women: Linking HIV Care and Treatment with Reproductive Health Services in the MTCT-Plus Initiative, Reproductive Health Matters, vol.365, issue.9460, pp.136-182, 2005.
DOI : 10.1016/S0968-8080(03)02174-8

B. Tonwe-gold, D. Ekouevi, C. Bosse, S. Toure, M. Koné et al., Implementing family-focused HIV care and treatment: the first 2???years??? experience of the mother-to-child transmission -plus program in Abidjan, C??te d???Ivoire, Tropical Medicine & International Health, vol.4, issue.2, pp.204-216, 2009.
DOI : 10.1111/j.1365-3156.2008.02182.x

B. Kirkwood and S. J. , Essential of Medical statistics, 2003.

R. Moh, C. Danel, S. Sorho, D. Sauvageot, A. Anzian et al., Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire, Antivir Ther, vol.10, issue.5, pp.615-639, 2005.

F. Ssali, W. Stöhr, P. Munderi, A. Reid, A. Walker et al., CF; DART Trial Team. Prevalence, incidence and predictors of severe anaemia with zidovudinecontaining regimens in African adults with HIV infection within the DART trial, Gilks

F. Forna, C. Liechty, P. Solberg, F. Asiimwe, W. Were et al., Clinical Toxicity of Highly Active Antiretroviral Therapy in a Home-Based AIDS Care Program in Rural Uganda, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.44, issue.4, pp.456-62, 2007.
DOI : 10.1097/QAI.0b013e318033ffa1

S. Bersoff-matcha, W. Miller, J. Aberg, C. Van-der-horst, H. Jr et al., Sex Differences in Nevirapine Rash, Clinical Infectious Diseases, vol.32, issue.1, pp.124-133, 2001.
DOI : 10.1086/317536

D. Dieterich, P. Robinson, J. Love, and J. Stern, Drug-Induced Liver Injury Associated with the Use of Nonnucleoside Reverse-Transcriptase Inhibitors, Clinical Infectious Diseases, vol.38, issue.Supplement 2, 2004.
DOI : 10.1086/381450

M. Sulkowski, D. Thomas, S. Mehta, R. Chaisson, and R. Moore, Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections, Hepatology, vol.284, issue.1, pp.182-191, 2002.
DOI : 10.1053/jhep.2002.30319

M. Chen, Ethnic or Racial Differences Revisited, Clinical Pharmacokinetics, vol.19, issue.5, pp.957-64, 2006.
DOI : 10.2165/00003088-200645100-00001

A. Cohort-collaboration, ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and highincome countries, Lancet, vol.367, issue.9513, pp.817-841, 2006.

J. Etard, I. Ndiaye, M. Thierry-mieg, N. Guèye, P. Guèye et al., Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study, AIDS, vol.20, issue.8, pp.1181-1190, 2006.
DOI : 10.1097/01.aids.0000226959.87471.01

D. Ekouevi, A. Inwoley, B. Tonwe-gold, C. Danel, R. Becquet et al., Variation of CD4 Count and Percentage during Pregnancy and after Delivery: Implications for HAART Initiation in Resource-Limited Settings, AIDS Research and Human Retroviruses, vol.23, issue.12, pp.1469-74, 2007.
DOI : 10.1089/aid.2007.0059

URL : https://hal.archives-ouvertes.fr/inserm-00201770